Smith, Salley & Associates
- SEC CIK
- 0001482012
- Latest filing
- Jul 23, 2026
AMGN holding history
Amgen Inc in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMGN overviewAll 13F holders of AMGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 11,307
- Value
- $4.09M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 11,307 | $4.09M | 0.2% | +205+1.8% | Added | Holders |
| Q1 2026 | 11,102 | $3.91M | 0.2% | +316+2.9% | Added | Holders |
| Q4 2025 | 10,786 | $3.53M | 0.2% | +30+0.3% | Added | Holders |
| Q3 2025 | 10,756 | $3.04M | 0.2% | +53+0.5% | Added | Holders |
| Q2 2025 | 10,703 | $2.99M | 0.2% | −100−0.9% | Reduced | Holders |
| Q1 2025 | 10,803 | $3.37M | 0.2% | −4,035−27.2% | Reduced | Holders |
| Q4 2024 | 14,838 | $3.87M | 0.2% | −10−0.1% | Reduced | Holders |
| Q3 2024 | 14,848 | $4.78M | 0.3% | +265+1.8% | Added | Holders |
| Q2 2024 | 14,583 | $4.56M | 0.3% | +71+0.5% | Added | Holders |
| Q1 2024 | 14,512 | $4.13M | 0.3% | −3,568−19.7% | Reduced | Holders |
| Q4 2023 | 18,080 | $5.21M | 0.3% | −480−2.6% | Reduced | Holders |
| Q3 2023 | 18,560 | $4.99M | 0.4% | −62−0.3% | Reduced | Holders |
| Q2 2023 | 18,622 | $4.13M | 0.3% | +4,196+29.1% | Added | Holders |
| Q1 2023 | 14,426 | $3.49M | 0.3% | +207+1.5% | Added | Holders |
| Q4 2022 | 14,219 | $3.73M | 0.3% | −3,207−18.4% | Reduced | Holders |
| Q3 2022 | 17,426 | $3.93M | 0.4% | +76+0.4% | Added | Holders |
| Q2 2022 | 17,350 | $4.22M | 0.4% | +680+4.1% | Added | Holders |
| Q1 2022 | 16,670 | $4.03M | 0.3% | +513+3.2% | Added | Holders |
| Q4 2021 | 16,157 | $3.63M | 0.3% | −462−2.8% | Reduced | Holders |
| Q3 2021 | 16,619 | $3.54M | 0.3% | +759+4.8% | Added | Holders |
| Q2 2021 | 15,860 | $3.87M | 0.3% | −20.0% | Reduced | Holders |
| Q1 2021 | 15,862 | $3.95M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.